NEW YORK--(BUSINESS WIRE)--ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that the Company is scheduled to present at the 2008 Citi Investment Research Global Health Care Conference in New York on Thursday, May 22, 2008 at 2:30 p.m. EDT. A corporate overview will be provided, including additional information on the Company’s product portfolio.
